Literature DB >> 18558136

Comparative study of robustness between micellar electrokinetic capillary chromatography and high-performance liquid chromatography using one-variable-at-a-time and a new multi-variable-at-a-time approach.

Rade Injac1, Marija Boskovic, Nina Kocevar, Tomaz Vovk.   

Abstract

Micellar electrokinetic capillary chromatography and reverse-phase liquid chromatography methods were developed in order to perform robustness testing to determine the caffeine content in beverages. Both methods were fully validated and two different robustness approaches were applied. One-variable-at-a-time (OVAT) approach at eleven levels (0; +/-1; +/-2; +/-3; +/-4; +/-5 units) was carried out and compared with multi-variable-at-a-time (MVAT) approach at three levels (+/-1 unit per investigated parameter). Four analysts in two laboratories on two capillary electrophoresis and two RPLC equipments have tested the samples. Robustness was statistically analyzed using peak area, migration or retention time, symmetry, and resolution of caffeine and sulfacetamide as internal standard, and presented as R.S.D. values. The RPLC method was found to be more sensitive than the MEKC method. Both methods showed acceptable robustness level for OVAT approach, whilst MEKC method was more robust when the determination of real samples coming from different beverages was based on the MVAT approach.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18558136     DOI: 10.1016/j.aca.2008.05.007

Source DB:  PubMed          Journal:  Anal Chim Acta        ISSN: 0003-2670            Impact factor:   6.558


  2 in total

1.  A high-throughput multivariate optimization for the simultaneous enantioseparation and detection of barbiturates in micellar electrokinetic chromatography-mass spectrometry.

Authors:  Bin Wang; Jun He; Shahab A Shamsi
Journal:  J Chromatogr Sci       Date:  2010-08       Impact factor: 1.618

2.  Oxidative status and lipofuscin accumulation in urothelial cells of bladder in aging mice.

Authors:  Martina Perše; Rade Injac; Andreja Erman
Journal:  PLoS One       Date:  2013-03-20       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.